A total of 77 T2DM patients (19.25%) were found to be positive for T. gondii IgG antibodies, as compared to 37 controls (9.25%), and the difference was statistically significant (p<0.001). T. gondii IgM antibodies were detected in 19 of the 400 T2DM patients and in 11 of the 400 controls (4.75% versus 2.75%, respectively, p=0.137). This evidence concerns the gene CD40LG and type 2 diabetes mellitus.